Newsletter 2021 – Q2

Research Roundup

Researchers Guide and Drive the Workbench’s First Year

May 27 marked the first anniversary of the All of Us Researcher Workbench beta launch. The Workbench, part of the Research Hub, houses data from over 315,000 participants. More than 800 researchers now have access to valuable data from sources including physical measurements, electronic health records, and surveys.

Read about the Researcher Workbench’s first year.

Spotlight: Meet the Researchers

Mitch Lunn, M.D., is an All of Us researcher and community engagement partner whose research focuses on the health needs of sexual and gender minority (SGM) people. His Stanford University group, PRIDEnet, is examining how SGM people may be at greater risk for health conditions due to different socioeconomic factors.

Learn more about Dr. Lunn and his All of Us research.

Featured Publication: “Precision Medicine in 2030—Seven Ways to Transform Healthcare”

In Cell’s March issue, All of Us CEO Joshua Denny, M.D., M.S., and NIH Director Francis S. Collins, M.D., Ph.D., discuss how cohorts, artificial intelligence, routine clinical genomics, and returning value across diverse populations can guide the future of precision medicine.

Also of note: In a new JAMA Viewpoint, leaders from across the consortium emphasize the scale and diversity of the All of Us participant cohort. They also discuss the Researcher Workbench, its rich dataset, and the ever-growing community of researchers using its powerful platform.

See more publications about All of Us.

All of Us News

Check out the latest news:

  • An All of Us study that tested blood samples for antibodies against SARS-CoV-2 found evidence of infections in five states earlier than had initially been reported. Read the complete study in Clinical Infectious Diseases. This data is now available in the Researcher Workbench.
  • Watch the All of Us Research Trainee webinar, airing on Thursday, June 24, 2021, 2–5 p.m. ET. Hear from All of Us program staff and current Workbench users and learn why the beta phase of this platform is an ideal environment for trainees.